Hypersensitive C-reactive protein-albumin ratio predicts symptomatic intracranial hemorrhage after endovascular therapy in acute ischemic stroke patients

Table 2 Logistic regression analysis for risk factors with symptomatic intracranial hemorrhage after endovascular therapy

Variable	Unadjusted OR (95%CI)	P	Adjusted OR (95%CI)	P
Demographic characteristics
Age, years	1.044 (1.008–1.081)	0.017	1.028 (0.984–1.074)	0.215
Male	0.958 (0.473–1.938)	0.904
Vascular risk factors
Hypertension	3.249 (1.228–8.594)	0.018	3.478 (0.956–12.657)	0.059
Diabetes mellitus	1.325 (0.593–2.959)	0.493
Dyslipidemia	0.512 (0.217–1.208)	0.126
Coronary heart disease	1.783 (0.849–3.746)	0.127
Atrial fibrillation	1.518 (0.746–3.089)	0.249
Previous stroke	1.038 (0.467–2.304)	0.927
Current drinking	0.720 (0.316–1.640)	0.434
Current smoking	0.661 (0.278–1.345)	0.221
Clinical data
Previous antiplatelet	3.225 (1.548–6.718)	0.002	4.940 (1.920–12.713)	0.001
SBP	1.017 (1.003–1.031)	0.019	1.012 (0.995–1.030)	0.174
DBP	0.995 (0.972–1.018)	0.667
Body mass index	1.005 (0.916–1.102)	0.919
Initial NIHSS	1.058 (1.011–1.107)	0.014	1.033 (0.970–1.101)	0.306
Intravenous thrombolysis	1.883 (0.944–3.755)	0.072
Time from door to puncture	1.002 (0.998–1.006)	0.329
Number of thrombectomy device passes	1.362 (1.046–1.772)	0.022	1.396 (0.982–1.985)	0.063
Poor collateral status	1.971 (0.976–3.980)	0.058
Successful recanalization	1.321 (0.445–3.925)	0.616
Stroke subtype, %
LAA	Reference
CE	0.799 (0.243–2.620)	0.711
Other subtype	1.605 (0.518–4.974)	0.412
Laboratory data
TC	0.906 (0.663–1.238)	0.535
TG	1.129 (0.831–1.532)	0.438
HDL	0.917 (0.338–2.487)	0.865
LDL	0.906 (0.621–1.322)	0.609
FBG	1.273 (1.140–1.421)	0.001	1.333 (1.145–1.552)	0.001
Homocysteine	1.000 (0.999–1.001)	0.865
HAR	10.994 (4.567–26.463)	0.001	12.384 (4.379–35.023)	0.001

Abbreviation: NIHSS, National institute of health stroke scale, SBP Systolic blood pressure, DBP Diastolic blood pressure, LAA Large-artery atherosclerosis, CE Cardioembolism, TC Total cholesterol, TG Triglyceride, LDL Low-density lipoprotein, HDL High-density lipoprotein, FBG Fasting blood glucose, HAR Hypersensitive C-reactive protein-albumin ratio

ISSN: 1471-2377